REFERENCES
1Dornhoffer JL, King D. The effect of the Meniett device in patients with Ménière’s disease: long-term results. Otol Neurotol 2008; 29(6): 868-74.
2Mattox DE, Reichert M. Meniett device for Ménière’s disease: use and compliance at 3 to 5 years. Otol Neurotol 2008; 29(1): 29-32.
3Weining H, Fang L, Bo G, Jinmei Z. Clinical long-term effects of Meniett pulse generator for Ménière’s disease. Acta Otolaryngol 2009; 129(8): 819-825.
4Barbara M, Monini S, Chiappini I, Filipo R. Meniett therapy may avoid vestibular neurectomy in disabling Ménière’s disease. Acta Otolaryngol 2007; 127(11): 1136-1141.
5Rajan GP, Din S, Atlas MD. Long-term effects of the Meniett device in Ménière’s disease: the Western Australian experience. J Laryngol Otol 2005; 119: 391-395.
6Thomsen J, Sass K, Ödkvist L, Arlinger S. Local over-pressure treatment reduces vestibular symptoms in patients with Ménière’s disease: a clinical, randomized, multicenter, double-blind, placebo-controlled study. Otol Neurotol 2005; 26: 68-73.
7Nabi S, Parnes LS. Bilateral Ménière’s disease. Curr Opin Otolaryngol Head Neck Surg 2009; 17: 356-362.
8Gates GA, Green Jr. JD, Tucci DL, Telian SA. The effects of transtympanic micropressure treatment in people with unilateral Ménière’s disease. Arch of Oto – HNS 2004; 130(6): 718-725.
9Gates GA, Verrall A, Green Jr. JD, Tucci DL, Telian SA. Meniett clinical trial: long-term follow-up. Arch Otolaryngol Head Neck Surg 2006; 132: 1311-1316.
10Densert B, Sass K. Control of symptoms in patients with Ménière’s disease using middle ear applications: two years follow-up. Acta Otolaryngol 2001; 121(5): 616-621.
11Ödkvist LM, Arlinger S, Billermark E, Densert B, Lindholm S, Wallquist J. Effects of middle ear pressure changes on clinical symptoms in patients with Ménière’s disease: A clinical, multicenter, placebo-controlled study. Acta Otolaryngol Suppl 2000; 543: 99-101.
12Densert B, Densert O, Arlinger S, Sass K, Ödkvist LM. Immediate effects of middle ear pressure changes on the electrocochleographic recordings in patients with Ménière’s disease: A clinical placebo-controlled study. 1997; Am J Otol 1997; 18: 726-733.
13Densert B, Densert O. Overpressure in treatment of Ménière’s disease. Laryngoscope 1982; 92:1285-1292.
14Densert B. Effects of overpressure on hearing function in Ménière’s disease. Acta Otolaryngol (Stockh)1987; 103:32-42.
15Feijen RA, Segenhout JM, Wit HP, Albers FWJ. Monitoring inner ear pressure changes in normal guinea pigs induced by the Meniett 20. Acta Otolaryngol 2000; 804-809.
16Densert B, Sass K, Arlinger S. Short-term effects of induced middle ear pressure changes on the electrocochleogram in Ménière’s disease. Acta Otolaryngol (Stockh) 1995; 115: 732-737.
17Lundgren CEG. Alternobaric vertigo – a diving hazard. Br Med J. 1965; 2:511-513.
18Tjernström Ö. 1974. Alternobaric vertigo. An experimental study in man of vertigo due to atmospheric pressure changes. Thesis, Malmö General Hospital. 1974.
19Ingelstedt S, Ivarsson A, Tjernström Ö. Immediate relief of symptoms during acute attacks of Ménière’s disease, using a pressure chamber. Acta Otolaryngol 1976; 82(5-6): 368-378.
20Younger R, Longridge NS, Mekjavic I. Effect of reduced atmospheric pressure on patients with fluctuating hearing loss due to Ménière’s disease. J Otolaryngol 1984; 13: 76-82.